Background: Many patients selected for potential resection of perihilar cholangiocarcinoma (PHC) 
INTRODUCTION
Perihilar cholangiocarcinoma (PHC) originates at or near the confluence of the hepatic bile ducts. 1 Patients treated with palliative chemotherapy have a median overall survival of only 12 months, 2 but curative-intent resection offers a median overall survival of 20 to 40 months. 3 Patients without evidence of metastatic or locally advanced disease on cross-sectional imaging or during staging laparoscopy are selected for exploratory laparotomy. Approximately 60% of these patients undergo a curative-intent resection. However, the other 40% of patients are intra-operatively diagnosed with metastatic or locally advanced disease, precluding a resection. 4, 5 Accurate prediction of the chance of a resection could thus be useful to inform patients and physicians before surgery. Moreover, identification of borderline resectable PHC would allow investigating neo-adjuvant treatment strategies to improve the resectability rate.
Several preoperative staging systems are available for PHC. The Bismuth classification stems from 1975 and is traditionally used to describe the extent of involvement of the bile ducts, without addressing any other variables. 6, 7 The Blumgart T-staging system was designed in 1998 and modified in 2001, and takes into account bile duct involvement, portal vein involvement, and lobar atrophy. 4, 8, 9 Nonetheless, patient characteristics and other radiologic variables may have additional predictive capacity. 5, 10 Moreover, indications for resection of PHC have gradually expanded after the introduction of extended resections. 11, 12 This study was designed to determine independent predictors of metastatic or locally advanced disease in patients selected for exploratory laparotomy and potential resection of PHC. The study includes patients from two referral centers and spans a relatively short time interval, ensuring homogeneity with respect to disease assessment and surgical approach. The aim was to develop a preoperative risk score that predicts the chance of a resection.
METHODS

Patients
Patients with presumed PHC were identified from prospective databases at Memorial Sloan Kettering Cancer Center (MSKCC, New York, USA) and the Academic Medical Center (AMC, Amsterdam, the Netherlands) between 2000 and 2014. Presumed PHC was defined as an apparent malignant biliary stricture originating in the common hepatic duct or in the hepatic duct confluence (Bismuth types 1 to 4), or in the left or right hepatic duct. 13 All consecutive patients who underwent exploratory laparotomy for potential curative-intent resection were included in this study. To adhere to the concept of identifying preoperative predictors, we also included patients who were found to have a different diagnosis after surgery (e.g. benign disease mimicking PHC). Tumor size was classified as not detectable/smaller than 1cm, between 1 and 3cm, or larger than 3 cm. 10 Metastases were suspected in N1 or N2 lymph nodes if they were larger than 10 mm in short-axis diameter or if they had central necrosis. 16 Lobar atrophy was defined as a small, often hypoperfused lobe with crowding of dilated intrahepatic bile ducts, and included patients who underwent portal vein embolization. 8, 17 71 4
Statistical analysis
A standard approach was used to develop a risk score. 18 Logistic regression analysis was used to identify predictors of an intra-operative diagnosis of distant-metastatic or locally advanced disease.
All study variables were first tested in univariable analysis and subsequently entered in multivariable analysis, which was additionally adjusted for age and sex. Subsequently, the independent predictors (P<0.05 in multivariable analysis) were selected into the risk score. Categories within the selected variables were collapsed if they had similar odds ratios. Regression coefficients of the collapsed predictors were then transformed into simple points to develop the risk score. Risk score quartiles were used to group patients into classes with increasing risk. Missing data was rare and handled with full-case analysis.
Finally, the performance of available Bismuth and Blumgart staging systems and the new risk score was evaluated. Predictive accuracy (discrimination) was assessed using area under the curve (AUC)
analysis with 95% confidence intervals (CIs). In addition, we also assessed the performance of the staging systems to predict mortality and survival after surgery using Kaplan-Meier analysis. Overall survival was determined between the date of surgery and the date of death or last follow-up. All statistical analyses were performed using SPSS, version 22.
RESULTS
Patients
A total of 501 patients underwent exploratory laparotomy for a curative-intent resection during the study period, and these patients were included in this study (n=252 from MSKCC and n=249 from AMC). There were 182 females (36.3%); mean age was 64 years. Preoperative biliary drainage for jaundice was used in 429 patients (85.6%). Staging laparoscopy prior to laparotomy had found no signs of metastases in 334 patients (66.7%); the other 167 patients (33.3%) underwent no staging laparoscopy. Baseline characteristics of the study population are shown in Table 1 .
Surgical procedures and diagnosis
A curative-intent resection was performed in 309 patients (61.7%). Extrahepatic bile duct resection was combined with a left (extended) hepatectomy in 120 patients (38.8%), a right (extended) hepatectomy in 124 patients (40.1%), a central hepatectomy in 3 patients (1.0%), a segment 4/5 wedge resection in 9 patients (2.9%), and no hepatectomy in 53 patients (17.2%). Caudate resection was used in 159 of 247 patients with a major hepatectomy (64.4%). A combined pancreatoduodenectomy was performed in 9 patients (2.9%), and portal vein reconstruction was used in 49 patients (15.6%). After resection, the diagnosis of PHC was confirmed in 268 patients (86.7%), but the resection specimen revealed cholangiocarcinoma from the distal bile ducts in 5 patients (1.6%), gallbladder carcinoma in 5 patients (1.6%), other malignancy in 4 patients (1.3%), and a benign stricture in 27 patients (8.7%). Among 282 patients with a resected malignancy, the definitive resection margin was tumor-negative (R0) in 220 patients (78.0%).
Resection was precluded in 192 patients (38.3%): 92 of these patients (47.9%) were found to have metastatic disease, and 100 patients (52.1%) were found to have locally advanced disease. Distant metastases involved N2 lymph nodes in 56 patients (29.2%), intrahepatic in 13 patients (6.8%), peritoneum in 10 patients (5.2%), transverse mesocolon in 1 patient (0.5%), and multiple sites in 12 patients (6.3%). Locally advanced disease consisted of excessive vascular involvement in 62 patients (32.3%), excessive biliary involvement in 27 patients (14.1%), and both in 11 patients (5.7%).
Multivariable analysis
Univariable and multivariable analysis of an intra-operative diagnosis of metastatic or locally advanced disease are shown in Table 2 . Jaundice, suspected metastases in lymph nodes, the extent of bile duct involvement, portal vein involvement, and hepatic artery involvement were 
Preoperative risk score
The proposed risk score is presented in Table 3 . The sum of the risk score ranges between 0 and 9 points, and 4 separate classes were identified: class 1 with 0-1 point, class 2 with 2 points, class 3 with 3-4 points, and class 4 with ≥5 points. Predicted risks according to the risk score are shown in Figure 1 . On the basis of this risk score, 82, 162, 189, and 39 patients were classified as class 1, 2, 3, and 4, respectively (29 patients could not be classified because vascular status on imaging (n=24) or lymph node status on imaging (n=5) was missing). 
Evaluation of preoperative staging systems
The Bismuth classification and Blumgart staging system were both predictive for an intra-operative diagnosis of metastatic or locally advanced disease and vice versa predicted resectability, as shown in Table 4 . However, the ability to discriminate between patients at high or low risk was suboptimal in both systems: the AUC of the Bismuth classification was 0.62 (95% CI 0.57-0.67), and the AUC of the Blumgart staging system was 0.65 (95% C 0.6-0.7). The proposed new risk score achieved an AUC of 0.75 (95% CI 0.7-0.79). (Table 4) Postoperative mortality
Postoperative mortality within 90-days after surgery occurred in patients who underwent a resection 
DISCUSSION
This study involved 501 patients with presumed PHC who were selected for exploratory laparotomy.
A resection was performed in 62%, but resection was precluded in 38% due to occult metastasis in 18% and locally advanced disease in 20%. Based on the independent predictors jaundice, suspected lymph node metastases, Bismuth type, portal vein involvement, and hepatic artery involvement, we developed a risk score that identified 4 separate classes. The risk score was predictive of both resectability and R0-resection, and had better discrimination than the Blumgart T-staging system and the Bismuth classification (AUC 0.75 versus 0.65 and 0.62, respectively). Moreover, the risk score was able to preoperatively predict survival after surgery.
Several staging systems are available for PHC at the time of diagnosis. The Bismuth classification describes the extent of biliary ductal involvement by tumor; although useful to some extent, it only minimally correlates with resectability in multivariable analysis. 6, 7 The Blumgart T-staging system takes into account the extent of bile duct involvement, portal vein involvement, and lobar atrophy. It was shown to predict metastatic disease and resectability in previous series from MSKCC, and has been the only available preoperative staging system for a long period. 4, 9 Nonetheless, indications for resection of PHC have gradually expanded since the introduction of extended resections.
11,12
The change is most notably observed in the number of patients with Blumgart stage T-3 tumors who underwent a resection, which was 0 out of 37 patients in the original series (period 1991-2000) as opposed to 64 out of 150 patients in the present series (period 2000-2014). The most important disadvantage of the Blumgart T-staging system pertains to lobar atrophy. Unilateral portal vein involvement with lobar atrophy was assumed to be associated with locally advanced disease, N Number of patients in the study * The area under the curve (AUC) relates to prediction of resectability 4 and classified as T-2. However, the present study showed that lobar atrophy is inversely associated with locally advanced disease, and is nearly significantly predictive of resectability.
A recent clinical staging system from the Mayo clinics includes multiple radiologic parameters (tumor size, tumor multiplicity, vascular involvement, and metastases) as well as performance status and CA 19-9 level. 19 It was shown to predict survival regardless of the treatment used, and could be useful especially for the design of clinical trials investigating systemic treatment or palliative care.
However, the derivation cohort included only 82 patients who underwent exploratory laparotomy for a potential resection, and had only minimal discriminatory power to predict survival in this subgroup (AUC 0.57). This inadequacy is most likely explained by the choice of variables in the staging system.
For example, we found that tumor size does not correlate with resectability. Moreover, the variable for vascular involvement, which is crucial when assessing resectability of PHC, is poorly defined in this staging system.
The conventional AJCC staging system is based on pathological findings. 1 Although it can also be applied to radiological parameters at the time of diagnosis (e.g. suspected metastases on imaging), it was shown unable to preoperatively predict resectability or survival. 
CHAPTER 4
There are several strengths to our study. The cohort represented a true population of patients undergoing surgery for presumed PHC, since patients with other disease mimicking PHC were also included from our databases (other malignancy 4.5%; benign disease 8.7%). Besides predicting an intra-operative diagnosis of metastatic or locally advanced disease and inversely predicting resectability, the risk score also preoperatively predicts survival after surgery. The 4 classes identified by the risk score adequately stratified patients for postoperative survival regardless of intra-operative findings or resections performed. Furthermore, a subgroup analysis showed that the risk score remained predictive of survival in patients who underwent a resection of confirmed PHC; possibly due to the higher percentage of R0 resections performed in the lower risk score classes. These assets of the risk score emphasize its usefulness in the design of future clinical trials that investigate neo-adjuvant treatment strategies.
The rates of postoperative mortality in the risk score classes can have major clinical implications.
Class 4 represents a very low probability of resection (15%), but a high probability of postoperative mortality within 90 days (19%) and a median survival of only 7 months. Therefore, the benefit of exploratory laparotomy is questionable in these patients: they might gain better quality of life and longer survival with best supportive care and palliative treatment.
We used solid definitions for variables that were considered as predictor, which were mostly based on a recent detailed classification system by DeOliveira et al. 10 Vascular involvement has been ill defined in previous studies, using definitions like 'encasement or proximity of tumor'. 5, 19 We chose to strictly classify vascular structures with more than 180 circumferential degrees tumor contact as involved and vascular structures with less than 180 circumferential degrees tumor contact as not involved. This definition provides a reproducible variable that proved useful as a predictor.
The size of the combined cohort of two participating centers enabled us to test all predictors in a full multivariable analysis. Jaundice was found to be an independent predictor (OR 2.1), and subsequently included in the risk score. Previous studies have found no correlation between suspect lymph nodes on imaging and lymph node metastasis, 20 but suspected lymph node metastases on imaging were nonetheless an independent predictor in the multivariable analysis. Suspected metastases in N1 nodes or N2 nodes yielded comparable risks of metastatic or locally advanced disease (OR 2.5 and 2.9, respectively), so these groups were collapsed in the risk score. The extent of bile duct involvement, as described in the Bismuth class, has been identified as a predictor of resectability in many studies, 3 which was corroborated in the present study. Patients with Bismuth type 2, 3A, and 3B tumors were collapsed in the risk score, because these groups had comparable risks in multivariable analysis. Finally, bilateral or main stem involvement of the portal vein and hepatic artery were found to be strongly predictive (OR 7.8 and 11.3, respectively). Patients with bilateral involvement of the hepatic artery were not purposefully selected for exploratory laparotomy.
However, some patients with bilateral hepatic artery involvement were included in the study because it was apparently missed during routine preoperative staging, and recovered during re-reviewing of the preoperative images. Bilateral portal vein involvement may be treated with portal vein resection Risk score to predict metastatic or locally advanced PHC 79 4 and reconstruction, and some authors have suggested routine portal vein resection. 21 Nonetheless, portal vein resection is not always technically feasible, and it is associated with an increased surgical risk. 22 These limitations may explain the reluctance of surgeons to perform a portal vein resection in some patients, and explain the predictive capacity of bilateral portal vein involvement in multivariable analysis. Interestingly, unilateral involvement of the portal vein and hepatic artery were found to be only modest predictors (OR 1.5 and 1.6, respectively). These factors do not influence the probability of a resection, as they are incorporated in the resection specimen of a standard hemihepatectomy.
Limitations of this study include its retrospective study design and study period. The quality of the preoperative imaging studies varied substantially during the study period. Especially patients from the earlier years of the cohort sometimes had low quality scans, which impaired the assessment of vascular involvement status. We used a strictly defined variable to categorize vascular involvement, and all scans were re-reviewed by specialized radiologists. Nonetheless, modern scans provide more detail and could have potentially improved adequacy of the risk score.
Secondly, we used the entire cohort for derivation of the staging system. This approach yielded a rigorous multivariable analysis and a promising staging system, but left no data for validation.
External validation of the staging system in future studies is thus highly desirable.
Thirdly, this study could not evaluate predictors of metastasis that may be recovered during staging
laparoscopy. An ideal staging system provides the probability of a resection at an early stage after diagnosis, i.e. prior to any intervention. The cohort in this study included patients who were selected for exploratory laparotomy after staging laparoscopy had already been performed. Therefore, future studies should test if the staging system also applies to patients selected for staging laparoscopy.
In conclusion, we developed a preoperative risk score that accurately predicts resectability, R0-resection, and postoperative survival among patients with presumed PHC. It can be useful in shareddecision making, and it will permit reliable stratification of patients for clinical trials investigating neoadjuvant treatment strategies.
